Bergapten

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Bergapten
DrugBank Accession Number
DB12216
Background

Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis).

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 216.192
Monoisotopic: 216.042258738
Chemical Formula
C12H8O4
Synonyms
  • 5 methoxypsoralen
  • 5-methoxypsoralen
External IDs
  • NSC-95437

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetohexamideThe therapeutic efficacy of Acetohexamide can be increased when used in combination with Bergapten.
ChlorpropamideThe therapeutic efficacy of Chlorpropamide can be increased when used in combination with Bergapten.
DexmethylphenidateThe serum concentration of the active metabolites of Bergapten can be increased when Bergapten is used in combination with Dexmethylphenidate.
DiazoxideThe serum concentration of Bergapten can be increased when it is combined with Diazoxide.
DoxycyclineThe therapeutic efficacy of Bergapten can be increased when used in combination with Doxycycline.
Food Interactions
Not Available

Categories

ATC Codes
D05BA03 — Bergapten
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as 5-methoxypsoralens. These are psoralens containing a methoxy group attached at the C5 position of the psoralen group.
Kingdom
Organic compounds
Super Class
Phenylpropanoids and polyketides
Class
Coumarins and derivatives
Sub Class
Furanocoumarins
Direct Parent
5-methoxypsoralens
Alternative Parents
1-benzopyrans / Benzofurans / Anisoles / Pyranones and derivatives / Alkyl aryl ethers / Heteroaromatic compounds / Furans / Lactones / Oxacyclic compounds / Organic oxides
show 1 more
Substituents
1-benzopyran / 5-methoxypsoralen / Alkyl aryl ether / Anisole / Aromatic heteropolycyclic compound / Benzenoid / Benzofuran / Benzopyran / Ether / Furan
show 10 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
organic heterotricyclic compound, psoralens, 5-methoxyfurocoumarin (CHEBI:18293) / Furanocoumarins (C01557) / a coumarin (5-METHOXYFURANOCOUMARIN)
Affected organisms
Not Available

Chemical Identifiers

UNII
4FVK84C92X
CAS number
484-20-8
InChI Key
BGEBZHIAGXMEMV-UHFFFAOYSA-N
InChI
InChI=1S/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H3
IUPAC Name
4-methoxy-7H-furo[3,2-g]chromen-7-one
SMILES
COC1=C2C=CC(=O)OC2=CC2=C1C=CO2

References

General References
Not Available
Human Metabolome Database
HMDB0030637
KEGG Compound
C01557
PubChem Compound
2355
PubChem Substance
347828496
ChemSpider
2265
BindingDB
50067880
RxNav
15842
ChEBI
18293
ChEMBL
CHEMBL24171
ZINC
ZINC000000057731
Wikipedia
Bergapten

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedTreatmentAtopic Dermatitis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.148 mg/mLALOGPS
logP2.12ALOGPS
logP1.78Chemaxon
logS-3.2ALOGPS
pKa (Strongest Basic)-2.8Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area48.67 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity56.85 m3·mol-1Chemaxon
Polarizability20.87 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000i-1920000000-1f376a338d3e06136886
GC-MS Spectrum - EI-BGC-MSsplash10-01b9-3890000000-a8341e87fa6830843ef7
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00y1-3940000000-1492cacf3f4395e9f66c
Mass Spectrum (Electron Ionization)MSsplash10-01b9-7950000000-e77dc647c2fa0ccbb177
LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSsplash10-0udi-0950000000-b19407bde306a78efe77
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0090000000-927b1385246a4f40d60d
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0uxr-0090000000-53c9077581fc1617f789
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0290000000-d6eb013ef1071457a5b1
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0gb9-0090000000-c9f12dbc22ea5656f07c
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0uxr-0190000000-7a948782b86b2057690c
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0190000000-e8c8dc33e2d74b5af54a
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0190000000-8bc360c878c7ddfb2135
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0090000000-d0dd8082e47d3cdf89c8
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0390000000-b51bcbe48eab7eb99e0f
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-01b9-0900000000-187f429d7e359302ca69
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0udi-0950000000-b19407bde306a78efe77
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0090000000-450a1c018dff429b792c
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-0090000000-e74edfc652a7a94313e0
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0090000000-fa8ee8ed54ff81feb55d
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-0190000000-4beb401b7c3afaf81e0c
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0390000000-7bde766662245d197038
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-2900000000-c1ae1bc1e11614a200ff
1H NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-149.1138756
predicted
DarkChem Lite v0.1.0
[M-H]-141.7330633
predicted
DarkChem Lite v0.1.0
[M-H]-149.0064756
predicted
DarkChem Lite v0.1.0
[M-H]-149.0398756
predicted
DarkChem Lite v0.1.0
[M-H]-143.31148
predicted
DeepCCS 1.0 (2019)
[M+H]+149.7389756
predicted
DarkChem Lite v0.1.0
[M+H]+149.5531756
predicted
DarkChem Lite v0.1.0
[M+H]+149.8682756
predicted
DarkChem Lite v0.1.0
[M+H]+149.9913756
predicted
DarkChem Lite v0.1.0
[M+H]+145.70705
predicted
DeepCCS 1.0 (2019)
[M+Na]+149.8197756
predicted
DarkChem Lite v0.1.0
[M+Na]+164.4968324
predicted
DarkChem Lite v0.1.0
[M+Na]+149.3147756
predicted
DarkChem Lite v0.1.0
[M+Na]+149.4752756
predicted
DarkChem Lite v0.1.0
[M+Na]+151.67436
predicted
DeepCCS 1.0 (2019)

Drug created at October 20, 2016 21:38 / Updated at June 12, 2020 16:53